RNAC

6.1404.24%
JS

June Seymour

Chief Accounting Officer

Ms. June Seymour is Chief Accounting Officer of Cartesian Therapeutics, Inc. from October 27, 2025. Ms. Seymour has financial leadership experience in the life sciences sector. She most recently served as Senior Vice President, Finance and Accounting at DNAnexus, Inc. since May 2024 and prior to that was Vice President, Finance at Neogene Therapeutics Inc., where she led her team through the company's sale to AstraZeneca and post-acquisition integration between January 2022 and May 2024. From 2019 to 2022, Ms. Seymour held roles of increasing responsibility at Autolus Ltd., including Executive Director, Finance and Senior Director, Financial Reporting. Earlier in her career, from 2003 to 2019, she was a Senior Manager at Ernst & Young LLP in London, specializing in U.S. transactions involving European life sciences companies. Ms. Seymour holds a Bachelor of Science in Business Administration and Accountancy from Methodist University and is a Certified Public Accountant.

公司职务